|
D1.2 Project website and visual identity
|
29/09/2017
|
MEDIRAD D1.2_Project website and visual identity.pdf
|
|
D2.1 Implementation of the prototype of the central DICOM repository
|
13/11/2019
|
MEDIRAD_D2.1_Implementation of the prototype of the central DICOM repository.pdf
|
|
D2.2 Implementation and testing of the RDF repository
|
28/05/2018
|
MEDIRAD D2.2_Implementation and testing of the RDF repository.pdf
|
|
D2.3 Report on system integration and publication of the basic user guidelines
|
13/11/2019
|
MEDIRAD_D2.3 Report on system integration and publication of the basic user guidelines.pdf
|
|
D2.4 Catalogue with Codes relevant for MEDIRAD project
|
13/11/2019
|
MEDIRAD_D2.4 Catalogue with Codes relevant for MEDIRAD project.pdf
|
|
D2.8 Report on the current use of multi-modality systems in nuclear medicine
|
13/11/2019
|
MEDIRAD D2.8_Report on the current use of multi-modality systems in nuclear medicine.pdf
|
|
D2.7 Six segmented thorax phantoms
|
04/06/2020
|
MEDIRAD_D2.7_Six segmented thorax phantoms.pdf
|
|
D2.7 Six segmented thorax phantoms - Attachments
|
04/06/2020
|
Phantoms.rar
|
|
D2.9 Comprehensive Reporting Templates and Pilot system for SR Reporting
|
29/05/2019
|
MEDIRAD D2.9_Comprehensive Reporting Templates and Pilot system for SR-Reporting.pdf
|
|
D2.10 European DRLs for specific applications of CT in multi-modality systems
|
11/03/2020
|
MEDIRAD D2.10_European DRLs for specific applications of CT in multi-modality systems.pdf
|
|
D2.11 Midterm recruitment report for radiopharmaceutical dosimetry study
|
13/01/2021
|
MEDIRAD D2.11_Midterm recruitment report for radiopharmaceutical dosimetry study_v2 final.pdf
|
|
D2.12 Correlation analysis between objective and subjective image quality in chest CT patient parameter and indication dependent
|
01/09/2020
|
MEDIRAD_D2.12_Correlation analysis between objective and subjective image quality_v2.pdf
|
|
D2.14 Report on a) the organ dose data representation and b) collected organ doses
|
29/05/2020
|
MEDIRAD_D2.14_Reprt on the organ dose data representation and collected organ doses.pdf
|
|
D 2.15 Organ dose conversion coefficients for the estimation of patient doses from CT for attenuation correction and anatomic localization in multi- modality imaging
|
31/10/2021
|
MEDIRAD_D2.15.pdf
|
|
D2.16 Report on status of posting results in the study registry(s) for WP2
|
31/10/2021
|
MEDIRAD_D2.16.pdf
|
|
D2.17 Update of administered activity-to-organ-dose conversion factors for two commonly used radiopharmaceuticals
|
02/02/2022
|
MEDIRAD_D2.17_final.pdf
|
|
D2.19 Report on effectiveness of protective devices for staff in interventional procedures
|
08/01/2021
|
MEDIRAD_D2.19_Report on effectiveness of protective devices_updated.pdf
|
|
D 2.21 Software tool (CT- IQURAD) module on image quality
|
31/10/2021
|
MEDIRAD_D2.21.pdf
|
|
D2.22 Software tool (CT-IQURAD) module on ratiation dose
|
02/06/2021
|
MEDIRAD D2.22_Software tool module on radiation dose .pdf
|
|
D2.23 Accelerated Monte Carlo code for an online patient monitoring system in interventional cardiology procedures
|
02/06/2021
|
MEDIRAD D2.23_Accelerated Monte Carlo code for an online patient monitoring.pdf
|
|
D3.1 Imaging and data collection study protocols
|
30/11/2017
|
MEDIRAD D3.1_Imaging and data collection study protocols.pdf
|
|
D3.2 Report on validation of centres for imaging network
|
01/06/2018
|
MEDIRAD_D3 2_Report on validation of centres for imaging networks.pdf
|
|
D3.3 Dosimetry protocol and software
|
30/05/2018
|
MEDIRAD_D3.3_Dosimetry protocol and software.pdf
|
|
D3.6 Midterm recruitment report
|
10/11/2020
|
MEDIRAD_D3.6_Midterm recruitment report.pdf
|
|
D3.7 Biokinetic model for treatment planning
|
26/03/2021
|
MEDIRAD_D3.7_Biokinetic model for treatment planning.pdf
|
|
D3.8 Guidelines and recommendations for quantitative I-131 imaging and dosimetry
|
26/03/2021
|
MEDIRAD_D3.8_Guidelines and recommendations for quantitative I131 imaging and dosimetry.pdf
|
|
D3.9 Report on the use of the DNA damage assay to determine radiosensitivity in patients
|
30/09/2021
|
MEDIRAD_deliverable_3.9_Report on the use of the DNA damage assay to determine radiosensitivity in patients.pdf
|
|
D3.10 Protocol for a large scale epidemiological study
|
15/02/2022
|
MEDIRAD_D3.10_final.pdf
|
|
D3.11 Report on status of posting results in the study registry(s) for WP3
|
18/02/2022
|
MEDIRAD_D3.11_final.pdf
|
|
D5.3 Midterm recruitment report. Recruitment applies only to the nested case control study
|
02/12/2019
|
MEDIRAD D5.3_Midterm recruitment report. Recruitment applies only to the nested case control study.pdf
|
|
D5.5 Report on estimated doses for the case-control study subjects
|
06/05/2021
|
MEDIRAD D5.5_Report on estimated doses for the case-control study subjects.pdf
|
|
5.6 Report on results of dose-response analyses from case-control study
|
18/01/2022
|
MEDIRAD_D5.6_final.pdf
|
|
5.8 Report on results of the analysis miRNA and lncRNA
|
20/12/2021
|
MEDIRAD_deliverable D5.8_final.pdf
|
|
D6.1 First Stakeholder Board annual report
|
28/05/2018
|
MEDIRAD D6.1_First Stakeholder Board Annual Report.pdf
|
|
D6.2 Report on the Stakeholder Forum
|
28/05/2018
|
MEDIRAD D6.2_Report on the Stakeholder Forum_excl Annex.pdf
|
|
D6.3 Second Stakeholder Board Annual Report
|
13/11/2019
|
MEDIRAD D6.3 Second Stakeholder Board Annual Report.pdf
|
|
D6.4 Third Stakeholder Board Annual Report
|
22/12/2020
|
MEDIRAD_D6.4_Third Stakeholder Board Annual Report.pdf
|
|
MS15 Establishment of expert groups, definition of clinical indications for chest CT, decision on clinical image quality criteria and readout working procedures
|
10/07/2018
|
MS15_WP2_Expert groups etc_M12.pdf
|
